Exicure conclui marco de ensaio clínico de Fase 2 e planeja pagamento de US$ 1 milhão à GPCR Therapeutics
Argenx, ServiceNow And Other Big Stocks Moving Lower In Monday's Pre-Market Session - argenx (NASDAQ:ARGX), Celldex Therapeutics (NASDAQ:CLDX)